To confirm the potential involvement of NF-κB in the mechanism of liver dysfunction associated with T2DM, it was important to investigate the transcriptional activity of NF-κB and its correlation with the delineated changes in the expression of NO synthases and key cytokines involved in inflammation. Here, NFKB1 is linked to type 2 diabetes mellitus.